1
/
of
1
Elabscience
SKU:PKSQ050122
Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc)
Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc), a cutting-edge product designed to revolutionize the field of immunology. This meticulously engineered receptor subunit offers unparalleled functionality and versatility, making it an indispensable tool for researchers and scientists alike.
Crafted with utmost precision, the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) boasts a fusion protein structure that combines the alpha subunit of the IL-3 receptor with the Fc region of human IgG1. This fusion enables enhanced stability, prolonged half-life, and improved binding affinity, ensuring optimal performance in a wide range of applications.
The Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) exhibits exceptional specificity, selectively binding to IL-3, a crucial cytokine involved in hematopoiesis and immune regulation. By targeting the IL-3 receptor, this product facilitates the investigation of IL-3-mediated signaling pathways, cellular responses, and the development of novel therapeutic strategies.
Furthermore, the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) offers unparalleled versatility, enabling its utilization in various experimental setups. Whether employed in cell-based assays, flow cytometry, immunoprecipitation, or other molecular biology techniques, this product consistently delivers reliable and reproducible results.
In addition to its exceptional performance, the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) is manufactured under stringent quality control measures, ensuring utmost purity, stability, and bioactivity. Each batch undergoes rigorous testing to guarantee its conformance to the highest industry standards, providing researchers with utmost confidence in their experimental outcomes.
In summary, the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) represents a groundbreaking advancement in immunological research. With its unrivaled functionality, specificity, versatility, and uncompromising quality, this product is poised to empower scientists in unraveling the complexities of IL-3 signaling and revolutionize the development of novel therapeutic interventions.
Crafted with utmost precision, the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) boasts a fusion protein structure that combines the alpha subunit of the IL-3 receptor with the Fc region of human IgG1. This fusion enables enhanced stability, prolonged half-life, and improved binding affinity, ensuring optimal performance in a wide range of applications.
The Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) exhibits exceptional specificity, selectively binding to IL-3, a crucial cytokine involved in hematopoiesis and immune regulation. By targeting the IL-3 receptor, this product facilitates the investigation of IL-3-mediated signaling pathways, cellular responses, and the development of novel therapeutic strategies.
Furthermore, the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) offers unparalleled versatility, enabling its utilization in various experimental setups. Whether employed in cell-based assays, flow cytometry, immunoprecipitation, or other molecular biology techniques, this product consistently delivers reliable and reproducible results.
In addition to its exceptional performance, the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) is manufactured under stringent quality control measures, ensuring utmost purity, stability, and bioactivity. Each batch undergoes rigorous testing to guarantee its conformance to the highest industry standards, providing researchers with utmost confidence in their experimental outcomes.
In summary, the Recombinant Cynomolgus IL-3 Receptor Subunit Alpha/IL-3RA/CD123 (C-Fc) represents a groundbreaking advancement in immunological research. With its unrivaled functionality, specificity, versatility, and uncompromising quality, this product is poised to empower scientists in unraveling the complexities of IL-3 signaling and revolutionize the development of novel therapeutic interventions.
Share
